ÖNDER, G. Ö. Et Al. 2022. Melatonin has an inhibitory effect on MCF-7 and MDA-MB-231 human breast cancer cell lines by inducing autophagy and apoptosis. FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.36, no.6 , 1038-1056.

ÖNDER, G. Ö., SEZER, G., Ozdamar, S., & YAY, A. H., (2022). Melatonin has an inhibitory effect on MCF-7 and MDA-MB-231 human breast cancer cell lines by inducing autophagy and apoptosis. FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.36, no.6, 1038-1056.

ÖNDER, GÖZDE Et Al. "Melatonin has an inhibitory effect on MCF-7 and MDA-MB-231 human breast cancer cell lines by inducing autophagy and apoptosis," FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.36, no.6, 1038-1056, 2022

ÖNDER, GÖZDE Ö. Et Al. "Melatonin has an inhibitory effect on MCF-7 and MDA-MB-231 human breast cancer cell lines by inducing autophagy and apoptosis." FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.36, no.6, pp.1038-1056, 2022

ÖNDER, G. Ö. Et Al. (2022) . "Melatonin has an inhibitory effect on MCF-7 and MDA-MB-231 human breast cancer cell lines by inducing autophagy and apoptosis." FUNDAMENTAL & CLINICAL PHARMACOLOGY , vol.36, no.6, pp.1038-1056.

@article{article, author={GÖZDE ÖZGE ÖNDER Et Al. }, title={Melatonin has an inhibitory effect on MCF-7 and MDA-MB-231 human breast cancer cell lines by inducing autophagy and apoptosis}, journal={FUNDAMENTAL & CLINICAL PHARMACOLOGY}, year=2022, pages={1038-1056} }